You must log in to view this page.

Black Diamond Therapeutics Inc.

NASDAQ: BDTX
Share price (3/25/25): $1.69
Market cap (3/25/25): $95.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Bb Biotech AG, Biotech Growth N V

News Filter

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, a Targeted Oncology Therapy

Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

BDTX-1535 Dose of 200 Mg Daily Selected for Pivotal Development; Favorable Tolerability Profile and No New Safety Signals Observed

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC